StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Brilinta / Brilique (ticagrelor) by Quarter

Brilinta / Brilique (ticagrelor) — Worldwide product sales ($M) ($M)

QuarterlyAnnual

AstraZeneca Brilinta / Brilique (ticagrelor): $80M in Q2 2026, down 62.8% from a year earlier. That is the lowest of the 42 quarters on record here.

Latest, Q2 2026
80
Period ended Jun 30, 2026
Change on a year earlier
-62.8%
215 in Q2 2025
History
42 quarters
Since Q1 2016
Sources
27
Documents cited below

Where the Q2 2026 figure comes from

“|| Brilinta | | 80 | | ( 62 ) | | ( 63 ) | | 2 | | ( 98 ) | | 66 | | 5 | | 3 | | 11 | | ( 79 ) | | ( 80 ) | | 1 | | ( 31 ) | | ( 17 )”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBrilinta / Brilique (ticagrelor) — Worldwide product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202680-62.8%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026105-65.6%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025158-53.7%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025146-55.4%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025215-37.1%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025305-5.6%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 2024341+3.6%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024327-1.2%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024342+3.3%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 2024323-3.3%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023329-4.6%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 2023331-2.1%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 2023331-5.4%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 2023334+2.8%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022345-0.9%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022338-9.9%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up brilinta / Brilique (ticagrelor)

Cite this data

StockData. (2026). AstraZeneca Brilinta / Brilique (ticagrelor) ($M), quarterly Q1 2016–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-brilinta-world

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.